EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Laser-Ablated Gold Nanoparticles as Tunable Contrast Agents for Preclinical Imaging

Yulia Finogenova iD, Vsevolod Skribitsky iD, Alexey Lipengolts iD, Angelina Skribitskaya iD, Anton Kasianov iD, Kristina Shpakova iD, Artem Laktionov iD, Islam Sozaev iD, Anna Smirnova iD, Elena Grigorieva iD

Nanomaterials · 10.12.2025 · 15 (24) · 1851

DOI: 10.3390/nano15241851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanomaterials, online erschienen am 10.12.2025. Verfasst von Yulia Finogenova und 9 weiteren Autor:innen. Beteiligte Einrichtung: N.N. Blokhin National Medical Research Center of Oncology, Moscow 115522, Russia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Economic Development of the Russian Federation: Grant Agreement from the Federal Budget in the form of a Subsidy to the Federal State Budgetary Ins….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Femtosecond laser-ablated gold nanoparticles (AuNPs) offer a unique platform for developing novel cost-effective contrast agents due to their ultraclean, surfactant-free synthesis and precisely tunable surface properties. This study developed three computed tomography (CT) contrast agents from a single stock solution of laser-ablated AuNPs, functionalized with polyethylene glycol (PEG-2kDa, PEG-4kDa), or lipoic acid with bovine serum albumin (BSA). The primary objective was to evaluate the safety and functional efficacy of these coated AuNPs in healthy and tumor-bearing mice. After a single intravenous injection (690 ± 30 mg Au/kg), all formulations were well tolerated with no acute toxicity observed. PEGylated AuNPs demonstrated long blood half-life (18 ± 2 h for PEG-2kDa; 37 ± 2 h for PEG-4kDa), making them suitable for cardiovascular imaging up to 24 h post-injection. BSA-AuNPs had a rapid blood clearance (T1/2 = 2.8 ± 0.9 h), permitting cardiovascular assessment during the first 3 h, and provided intense, persistent contrast in abdominal organs, enabling liver imaging from 5 min and spleen imaging from 1 h post-injection. In a Ca755 mammary adenocarcinoma model, PEGylated AuNPs selectively accumulated in the tumor stroma and fibrous septa, allowing for precise tumor margin delineation and analysis of internal architecture. The findings establish that a single AuNP stock can be used to produce specialized contrast agents for specific imaging applications.

Schlagwörter

Stichwörter der Autor:innen

acute toxicitybiodistributioncomputed tomographycontrast agentsgold nanoparticlesmammary adenocarcinoma Ca755nanoparticle coatingpharmacokineticspreclinical studiestumor targeting

Autor:innen und Institutionen

  • N.N. Blokhin National Medical Research Center of Oncology, Moscow 115522, Russia.
  • Engineer and Physics Institute of Biomedicine, National Research Nuclear University MEPhI, Moscow 115409, Russia.
  • Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences, Moscow 119991, Russia.
  • The Loginov Moscow Clinical Scientific Center, Moscow 111123, Russia.

ORCID-Profile: Yulia Finogenova, Vsevolod Skribitsky, Alexey Lipengolts, Angelina Skribitskaya, Anton Kasianov, Kristina Shpakova, Artem Laktionov, Islam Sozaev, Anna Smirnova, Elena Grigorieva

Förderung

  • Ministry of Economic Development of the Russian Federation: Grant Agreement from the Federal Budget in the form of a Subsidy to the Federal State Budgetary Ins…

Zitieren

APA

Finogenova, Y., Skribitsky, V., Lipengolts, A., Skribitskaya, A., Kasianov, A., Shpakova, K., Laktionov, A., Sozaev, I., Smirnova, A., & Grigorieva, E. (2025). Laser-Ablated Gold Nanoparticles as Tunable Contrast Agents for Preclinical Imaging. Nanomaterials, 15(24), 1851. https://doi.org/10.3390/nano15241851

Vancouver

Finogenova Y, Skribitsky V, Lipengolts A, Skribitskaya A, Kasianov A, Shpakova K, et al. Laser-Ablated Gold Nanoparticles as Tunable Contrast Agents for Preclinical Imaging. Nanomaterials. 2025;15(24):1851. doi:10.3390/nano15241851

BibTeX
@article{Finogenova2025,
  author = {Finogenova, Yulia and Skribitsky, Vsevolod and Lipengolts, Alexey and Skribitskaya, Angelina and Kasianov, Anton and Shpakova, Kristina and Laktionov, Artem and Sozaev, Islam and Smirnova, Anna and Grigorieva, Elena},
  title = {Laser-Ablated Gold Nanoparticles as Tunable Contrast Agents for Preclinical Imaging},
  journal = {Nanomaterials},
  year = {2025},
  volume = {15},
  number = {24},
  pages = {1851},
  doi = {10.3390/nano15241851}
}
Kostenlos starten →